Table 2. Results of qPCR for detection of RLW DNA in blood or tissue of rats involved in Trial I and Trial II.
Trial I n = 5 rats/treatment | Trial II n = 2 rats/treatment | |||||
---|---|---|---|---|---|---|
Treatment | Time PI | Number of qPCR replicates/ rat 1 | Number of rats positive 2 | Time PI | Number of qPCR replicates/ rat 3 | Number of rats positive 2 |
Control | pre-bleed | 4 | 0 | pre-bleed | 4, 8 | 0 |
4–7 hrs | 4 | 0 | 45–55 mins | 4 | 0 | |
21–24 hrs | 4 | 0 | 2–2:20 hrs | 4 | 0 | |
day 2 | 4 | 0 | 14–15 hrs | 4 | 0 | |
day 3 | 4 | 0 | 16–17 hrs | 4 | 0 | |
week 1 | 4 | 0 | 18–19 hrs | 4 | 0 | |
week 2 | 4 | 0 | Week 4 | 2, 4 | 0 | |
wk 6 cardiac | 2 | 0 | Week 5 | 2 | 0 | |
wk 6 tail | 8 | 0 | Week 6 | 2, 4 | 0 | |
Low dose | pre-bleed | 4 | 0 | pre-bleed | 2 | 0 |
4–7 hrs | 4 | 0 | 30–35 mins | 2 | 0 | |
21–24 hrs | 4 | 0 | 1:30 hrs | 2, 6 | 1 | |
day 2 | 4 | 0 | 14–15 hrs | 2 | 0 | |
day 3 | 4 | 0 | 16–17 hrs | 2 | 0 | |
week 1 | 4 | 0 | 18–19 hrs | 2 | 0 | |
week 2 | 4 | 0 | Week 4 | 2, 4 | 0 | |
week 6 cardiac | 2 | 5 | Week 5 | 4 | 1 | |
wk 6 tail | 12 | 3 | Week 6 | 2, 4 | 2 | |
High dose | pre-bleed | 4 | 0 | pre-bleed | 2 | 0 |
4–7 hrs | 4 | 0 | 50–60 mins | 2, 6 | 1 | |
21–24 hrs | 4 | 0 | 2–2:15 hrs | 2 | 0 | |
day 2 | 4 | 0 | 14–15 hrs | 2 | 0 | |
day 3 | 4 | 0 | 16–17 hrs | 2 | 0 | |
week 1 | 4 | 0 | 18–19 hrs | 2 | 1 | |
week 2 | 4 | 0 | Week 4 | 2 | 0 | |
week 6 cardiac | 2 | 5 | Week 5 | 4, 5 | 2 | |
wk 6 tail | 12 | 5 | Week 6 | 2 | 2 |
High dose infection (HD, 50 larvae/ml gavage), low dose (LD, 10 larvae/ml gavage), control (C, 0 larvae/ml gavage).
1One extraction per individual except wk 6 tail: tail tissue, which had two extractions per individual for controls, 3 extractions per individual for infected.
2Positive = clear signal in large proportion of replicates
3If the number of replicate qPCR tests differed between the two individuals, they are reported separately.